determination and the implementation of preventive, diagnostic or therapeutic medical
strategies. However, the ESC Guidelines do not override in any way whatsoever the …

Aims Patients with acute pulmonary embolism (PE) classified as low risk by the Pulmonary
Embolism Severity Index (PESI), its simplified version (sPESI), or the Hestia criteria may be …

Aims Pulmonary embolism (PE) is the third most common cardiovascular cause of death;
systemic thrombolysis is potentially lifesaving treatment in patients presenting with …

Objectives: The aim of this study was to evaluate the safety and effectiveness of
percutaneous mechanical thrombectomy using the FlowTriever System (Inari Medical, Irvine …

Background European estimates of the burden imposed by pulmonary embolism are not
available to this date. We aimed to assess pulmonary embolism-related mortality and time …

Background Pulmonary embolism (PE)-related mortality is decreasing in Europe. However,
time trends in the USA and Canada remain uncertain because the most recent analyses of …

not override in any way whatsoever the individual responsibility of health professionals to
make appropriate and accurate decisions in consideration of each patient's health condition …

Background: The long-term effect of thrombolytic treatment of pulmonary embolism (PE) is
unknown. Objectives: This study investigated the long-term prognosis of patients with …

Pulmonary embolism (PE) is the leading cause of in-hospital death and the third most
frequent cause of cardiovascular death. The clinical presentation of PE is variable, and …

Intermediate–high-risk pulmonary embolism (PE) is characterized by right ventricular (RV)
dysfunction and elevated circulating cardiac troponin levels despite apparent hemodynamic …